A Summary of ALECSAT

Cell-based immunotherapy such as ALECSAT is well tolerated and have very few side effects as demonstrated in all clinical programs.

ALECSAT has specificity for and recognizes different cancer-specific antigens.

ALECSAT will also be efficacious in patients with inhibited immune defense mechanisms.

ALECSAT has three potential modes of actions:

  1. Direct cancer-cell destruction by way of the cytotoxic T lymphocytes (CTL’s) and natural killer (NK) cells administered via injection to the patient.
  2. Persistent cancer-cell destruction as the ALECSAT cells will continue to divide to higher numbers of new CTL’s.
  3. Reactivation of the patient’s own immune system may also lead to persistent destruction of new cancer cells.
Error, cant find that post.